{"hq_id":"hq-p-spe-000080","name":"VR/AR Headset (Eye Strain, Motion Sickness, Hygiene)","category":{"primary":"specialty","secondary":"electronics","tags":["VR","AR","headset","Meta Quest","eye strain","motion sickness","IPD","hygiene"]},"product_tier":"SPE","overall_risk_level":"low","description":"Virtual and augmented reality headsets (Meta Quest, Apple Vision Pro, PlayStation VR) presenting eye strain from vergence-accommodation conflict, motion sickness (20-80% prevalence), hygiene concerns from shared facial interface foam, and BFR flame retardants in housing. Manufacturer age restrictions: Meta Quest 13+, PlayStation VR 12+. Children's developing visual systems may be more susceptible to vergence-accommodation stress. No long-term studies on VR use effects on developing vision.","synthesis":{"derived_risk_level":"moderate_to_high","synthesis_confidence":0.703,"synthesis_method":"compound_composition","context_used":"human_child","context_source":"product_users","exposure_modifier":1.05,"vulnerability_escalated":true,"escalation_reason":"Child exposure group","compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"children under 13 (developing vision), motion sickness-prone individuals","overall_risk":"low","primary_concerns":["Vergence-accommodation conflict causing eye strain and headache","Motion sickness prevalence 20-80% (higher in new users)","No long-term data on developing visual system effects in children","Shared facial interface hygiene (bacterial/fungal transfer)"],"exposure_routes":"Ocular (vergence conflict, blue light); dermal (facial interface contact)"},"exposure":{"routes":["ocular","dermal"],"contact_types":["ocular","skin_prolonged"],"users":["adult","child"],"duration":"hours","frequency":"weekly","scenarios":["Vergence-accommodation conflict causing eye strain and headaches","Motion sickness in 20-80% of users (worse in early sessions)","Shared facial interface: bacterial/fungal transfer in arcades and demos","BFR off-gassing from heated electronics housing near face"],"notes":"Vergence-accommodation conflict: VR displays are at fixed focal distance (~2m equivalent) while vergence tracks virtual object distance — this mismatch causes eye strain. Children under 7 have developing binocular vision — VR may interfere with stereopsis development. Motion sickness decreases with repeated use (habituation). Clean facial interface between users in shared/demo settings."},"consumer_guidance":{"usage_warning":"Follow manufacturer age restrictions (13+ for most headsets). Take 10-15 minute breaks every 30 minutes. Stop immediately if experiencing nausea, dizziness, or eye strain. Clean facial interface between users. Start with stationary experiences before movement-intensive content.","safer_alternatives":["AR/mixed reality (maintains real-world visual reference — less motion sickness)","Shorter VR sessions with frequent breaks","Personal facial interface foam (not shared)","Age-appropriate use following manufacturer guidelines"],"red_flags":[{"indicator":"Non-certified or counterfeit electronic product","meaning":"May lack safety protections.","action":"Buy from reputable brands with UL/FCC certification."}],"green_flags":[{"indicator":"UL, FCC, or CE certification mark","meaning":"Tested to applicable safety standards.","verification":"Verify certification on manufacturer website."}],"what_to_ask":[{"question":"Does this product have applicable safety certifications?","why_it_matters":"Certification verifies electrical safety, EMF compliance, and material standards.","good_answer":"UL listed, FCC certified, CE marked.","bad_answer":"No certifications or unknown brand."}],"alternatives":[{"name":"AR/mixed reality","notes":"maintains real-world visual reference — less motion sickness"},{"name":"Shorter VR sessions with frequent breaks","notes":"Alternative"},{"name":"Personal facial interface foam","notes":"not shared"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA — California","regulation":"California Proposition 65 (Safe Drinking Water and Toxic Enforcement Act of 1986)","citation":null,"requirements":"Products containing chemicals on the Prop 65 list require clear and reasonable warnings if exposure exceeds safe harbor levels. Applies to products sold in California.","compliance_status":null,"effective_date":null,"enforcing_agency":null,"penalties":null,"source_ref":null},{"jurisdiction":"EU","regulation":"REACH Regulation (EC) No 1907/2006","citation":null,"requirements":"Registration, Evaluation, Authorisation and Restriction of Chemicals. Articles containing SVHCs >0.1% w/w must notify ECHA and inform consumers on request.","compliance_status":null,"effective_date":null,"enforcing_agency":null,"penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"E-waste recycling.","hazardous_waste":false,"expected_lifespan":"3-5_years"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-org-000223","name":"Decabromodiphenyl ether (DecaBDE / BDE-209)","role":"housing_BFR","concentration_pct":"1-5"}],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000223","compound_name":null,"role":"housing_BFR","typical_concentration":"1-5%"}],"identifiers":{"common_names":["vr/ar headset (eye strain, motion sickness, hygiene)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"3M","manufacturer":"3M","market_position":"mass_market","notable":"Safety and specialty product conglomerate"},{"brand":"Honeywell","manufacturer":"Honeywell","market_position":"mass_market","notable":"Safety equipment and technology"},{"brand":"DuPont","manufacturer":"DuPont","market_position":"professional","notable":"Chemical and safety products"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"California Proposition 65 (Safe Drinking Water and Toxic Enforcement Act of 1986)","jurisdiction":"USA — California","id":"src_c8d390dd"},{"type":"regulation","title":"REACH Regulation (EC) No 1907/2006","jurisdiction":"EU","id":"src_7b98e8e0"},{"id":"stockholm_decabde_2017","type":"regulatory","title":"Stockholm Convention: Decabromodiphenyl Ether (DecaBDE) Listed under Annex A (Elimination), COP-8 Decision SC-8/12, Debromination Concern, Arctic Contamination, RoHS Interaction, Aircraft Exemptions (2017)","year":2017,"inherited_from_compound":"hq-c-org-000223"},{"id":"eu_rohs_decabde","type":"regulatory","title":"EU Directive 2011/65/EU (RoHS Recast): DecaBDE Restricted in EEE; DecaBDE REACH SVHC Identification; Debromination Products BDE-47/BDE-99 Metabolite Pathway in Humans and Wildlife (2011)","year":2011,"inherited_from_compound":"hq-c-org-000223"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-14T01:23:45.784Z"}}